SATOL Launches Inaugural Session Featuring TestOneLife's Insights on Home-Based Precision Micro-Diagnostics

2022 marked the third year of implementing the Healthy China Action strategy, and promoting the shift from a “disease-treatment-centered” approach to a “people’s health-centered” approach is a key focus and practice across the entire health industry.

Precision medical testing technologies have garnered significant attention since their inception, owing to the boundless possibilities they demonstrate in various application fields. Home-based precision micro-testing further emphasizes the home setting, enabling tests that were previously confined to hospitals to be conducted more conveniently and rapidly without compromising accuracy—specifically, by collecting samples at home and completing the analysis via cloud-based testing. Whether it is the rapidly emerging home genetic testing industry or the increasingly prevalent home-based early cancer screening sector coming into the spotlight, both adopt a lightweight and convenient approach. This has shattered traditional perceptions of medical testing and introduced new solutions for the early screening, diagnosis, and treatment of diseases.

On August 25, SATOL, a public welfare platform initiated by the World Life Science and Technology Conference, announced that it would join forces with Yisheng Jiankang, an innovative enterprise in life science and technology, to co-host the first episode of its online live broadcast series titled “Innovation and Leapfrog Development in Home-Based Precision Micro-Testing in the Era of Big Health.” The event will focus on home-based precision micro-testing technologies and features distinguished speakers including Dr. Zhou Jianhong, Chief Physician of Gynecology at the Women’s Hospital School of Medicine Zhejiang University, doctoral supervisor, one of the founders of the Chinese Branch of the International Society of Gynecological Endocrinology, and Chair of the Menopause Healthcare Committee of the China Maternal and Child Health Association; Professor Yang Weiping, an expert in the in vitro diagnostics (IVD) field, specially appointed professor at the Liver Disease Research Center of Capital Medical University, and Chief Scientist at Yisheng Jiankang; and Mr. Wang Qiangyu, former Vice President of Alibaba DingTalk, as well as Founder and CEO of Yisheng Jiankang. Together, they will comprehensively explore how to integrate internet technologies to establish a closed-loop service system for ovarian health management throughout women’s entire life cycles.

Publication Time:August 25, 2022, 20:30–21:30

Live Streaming Access:

Yisheng Jiankang is a life science technology innovation company dedicated to the mission of “providing lifelong testing and health management services for the public.” Positioned in the internet health sector, the company adheres to the core service philosophy of “one-time testing, lifelong management.” It brings together an interdisciplinary team of experts spanning pathology, clinical medicine, biological testing, internet technology, and artificial intelligence (AI) to provide women with comprehensive ovarian health management services throughout their entire life cycle. By leveraging precise, professional, and leading-edge in vitro diagnostic technologies integrated with cloud computing, big data, and AI, Yisheng Jiankang enables individuals to conveniently complete at-home testing. Combined with interpretations from expert consultants, the company establishes accessible and comprehensive cloud-based monitoring data, offering complete solutions for women’s health testing and management.

SATOL Release, a public welfare platform initiated by the World Life Science Conference, aims to focus on the field of life sciences, identify outstanding innovative enterprises and entrepreneurial teams, and release their innovative diagnostic and therapeutic technologies and products, thereby contributing to the application of advanced technologies in overcoming medical challenges, promoting clinical adoption, and achieving equitable access to healthcare.

The event will invite outstanding enterprises from fields such as life omics, precision medicine, innovative therapies, medical AI, robotic surgery, 3D printing, and regenerative medicine—covering annual frontier technologies, hot investment sectors, and emerging technologies—as well as industry peers whose companies have achieved excellent clinical data, breakthrough diagnostic and therapeutic outcomes, or innovative commercial value, and have gained recognition from multiple rounds of institutional investors.

Going forward, SATOL will be released in a format combining “online release + the Annual Launch Event of SATOL’s New Forces in Life Sciences at the World Life Science and Technology Conference.”

● SATOL Online Release: Conducted via live streaming twice a month.

● SATOL Annual Launch Event for Emerging Forces in Life Sciences at the World Life Science and Technology Conference: Held as an in-person event concurrently with the annual World Life Science and Technology Conference, this platform selects the most outstanding projects from those participating in the “SATOL Launch” to showcase their latest achievements online to over 20 academicians, more than 200 national experts, and upwards of 20,000 industry veterans.